Find Lomitapide manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

KDMF

KDMF

0

VMF

NDC API

API REF. PRICE (USD/KG)

MARKET PLACE

0

FDF

FINISHED DOSAGE FORMULATIONS

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

US Exclusivities

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

GLOBAL SALES INFORMATION

Annual Reports

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 202914-84-9, Bms 201038-04, Lomitapide (mesylate), Aegr-733 mesylate, Bms-201038-04, Lomitapide mesilate
Molecular Formula
C40H41F6N3O5S
Molecular Weight
789.8  g/mol
InChI Key
QKVKOFVWUHNEBX-UHFFFAOYSA-N
FDA UNII
X4S83CP54E

Lomitapide
Lomitapide Mesylate is a methanesulfonic acid form of lomitapide, a small molecule inhibitor of microsomal triglyceride transfer protein.
1 2D Structure

Lomitapide

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
methanesulfonic acid;N-(2,2,2-trifluoroethyl)-9-[4-[4-[[2-[4-(trifluoromethyl)phenyl]benzoyl]amino]piperidin-1-yl]butyl]fluorene-9-carboxamide
2.1.2 InChI
InChI=1S/C39H37F6N3O2.CH4O3S/c40-38(41,42)25-46-36(50)37(33-13-5-3-10-30(33)31-11-4-6-14-34(31)37)21-7-8-22-48-23-19-28(20-24-48)47-35(49)32-12-2-1-9-29(32)26-15-17-27(18-16-26)39(43,44)45;1-5(2,3)4/h1-6,9-18,28H,7-8,19-25H2,(H,46,50)(H,47,49);1H3,(H,2,3,4)
2.1.3 InChI Key
QKVKOFVWUHNEBX-UHFFFAOYSA-N
2.1.4 Canonical SMILES
CS(=O)(=O)O.C1CN(CCC1NC(=O)C2=CC=CC=C2C3=CC=C(C=C3)C(F)(F)F)CCCCC4(C5=CC=CC=C5C6=CC=CC=C64)C(=O)NCC(F)(F)F
2.2 Other Identifiers
2.2.1 UNII
X4S83CP54E
2.3 Synonyms
2.3.1 Depositor-Supplied Synonyms

1. 202914-84-9

2. Bms 201038-04

3. Lomitapide (mesylate)

4. Aegr-733 Mesylate

5. Bms-201038-04

6. Lomitapide Mesilate

7. Lomitapide Mesylate [usan]

8. Aegr-733 Mesilate

9. X4s83cp54e

10. Chebi:72299

11. 202914-84-9 (mesylate)

12. N-(2,2,2-trifluoroethyl)-9-(4-(4-(4'-(trifluoromethyl)biphenyl-2-ylcarboxamido)piperidin-1-yl)butyl)-9h-fluorene-9-carboxamide Methanesulfonate

13. Lomitapide Mesilate (jan)

14. Lomitapide Mesylate (usan)

15. N-(2,2,2-trifluoroethyl)-9-(4-(4-(4'-(trifluoromethyl)-[1,1'-biphenyl]-2-carboxamido)piperidin-1-yl)butyl)-9h-fluorene-9-carboxamide Methanesulfonate

16. Lomitapide Mesilate [jan]

17. 9h-fluorene-9-carboxamide, N-(2,2,2-trifluoroethyl)-9-(4-(4-(((4'-(trifluoromethyl)(1,1'-biphenyl)-2-yl)carbonyl)amino)-1-piperidinyl)butyl)-, Methanesulfonate

18. Methanesulfonic Acid;n-(2,2,2-trifluoroethyl)-9-[4-[4-[[2-[4-(trifluoromethyl)phenyl]benzoyl]amino]piperidin-1-yl]butyl]fluorene-9-carboxamide

19. Unii-x4s83cp54e

20. Juxtapid (tn)

21. N-(2,2,2-trifluoroethyl)-9-(4-(4-(((4'-(trifluoromethyl)biphenyl-2-yl)carbonyl)amino)piperidin-1-yl)butyl)-9h-fluorene-9-carboxamide Methanesulfonate

22. N-(2,2,2-trifluoroethyl)-9-{4-(4-({(4'-(trifluoromethyl)biphenyl-2-yl)carbonyl}amino)piperidin-1-yl)butyl}-9h-fluorene-9-carboxamide Methanesulfonate

23. N-(2,2,2-trifluoroethyl)-9-{4-[4-({[4'-(trifluoromethyl)biphenyl-2-yl]carbonyl}amino)piperidin-1-yl]butyl}-9h-fluorene-9-carboxamide Methanesulfonate

24. Lojuxta (tn)

25. Lomitapide Monomesylate

26. Lomitapide Methanesulfonate

27. Bms-201038 Mesylate

28. Schembl2731380

29. Chembl2105662

30. Dtxsid60174170

31. Ex-a502

32. Bms-201038ma

33. Glxc-25701

34. Amy38734

35. Bcp10696

36. Cia91484

37. Lomitapide Mesilate [who-dd]

38. Mfcd19443682

39. S7633

40. Akos025149431

41. Ccg-270481

42. Cs-3424

43. Lomitapide Mesylate [orange Book]

44. Ac-33863

45. As-56518

46. Da-33433

47. Hy-14668

48. Ft-0700260

49. D09638

50. J-690260

51. Q27139887

52. 1-(4-{9-[(2,2,2-trifluoroethyl)carbamoyl]-9h-fluoren-9-yl}butyl)-4-({[4'-(trifluoromethyl)biphenyl-2-yl]carbonyl}amino)piperidinium Methanesulfonate

53. 2059395-52-5

54. 9h-fluorene-9-carboxamide, N-(2,2,2-trifluoroethyl)-9-(4-(4-(((4'-(trifluoromethyl)(1,1'-biphenyl)-2-yl)carbonyl)amino)-1-piperidinyl)butyl)-, Methanesulphonate

55. Aegr-733 Mesylate;bms-201038 Mesylate;aegr733 Mesylate;bms201038 Mesylate;aegr 733 Mesylate;bms 201038 Mesylate

56. N-(2,2,2-trifluoroethyl)-9-(4-(4-(((4'-(trifluoromethyl)biphenyl-2-yl)carbonyl)amino)piperidin-1-yl)butyl)-9h-fluorene-9-carboxamide Methanesulphonate

57. N-(2,2,2-trifluoroethyl)-9-[4-(4-{2-[4-(trifluoromethyl)phenyl]benzamido}piperidin-1-yl)butyl]-9h-fluorene-9-carboxamide; Methanesulfonic Acid

2.4 Create Date
2006-10-26
3 Chemical and Physical Properties
Molecular Weight 789.8 g/mol
Molecular Formula C40H41F6N3O5S
Hydrogen Bond Donor Count3
Hydrogen Bond Acceptor Count12
Rotatable Bond Count10
Exact Mass789.26711156 g/mol
Monoisotopic Mass789.26711156 g/mol
Topological Polar Surface Area124 Ų
Heavy Atom Count55
Formal Charge0
Complexity1200
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count2
4 Drug and Medication Information
4.1 Drug Information
1 of 2  
Drug NameJuxtapid
PubMed HealthLomitapide (By mouth)
Drug ClassesAntihyperlipidemic
Drug LabelJUXTAPID capsules contain lomitapide mesylate, a synthetic lipid-lowering agent for oral administration.The chemical name of lomitapide mesylate is N-(2,2,2-trifluoroethyl)-9-[4-[4-[[[4'-(trifluoromethyl)[1,1'-biphenyl]-2-yl]carbonyl]amino]-1-pi
Active IngredientLomitapide mesylate
Dosage FormCapsule
RouteOral
Strengtheq 5mg base; eq 20mg base; eq 10mg base
Market StatusPrescription
CompanyAegerion

2 of 2  
Drug NameJuxtapid
PubMed HealthLomitapide (By mouth)
Drug ClassesAntihyperlipidemic
Drug LabelJUXTAPID capsules contain lomitapide mesylate, a synthetic lipid-lowering agent for oral administration.The chemical name of lomitapide mesylate is N-(2,2,2-trifluoroethyl)-9-[4-[4-[[[4'-(trifluoromethyl)[1,1'-biphenyl]-2-yl]carbonyl]amino]-1-pi
Active IngredientLomitapide mesylate
Dosage FormCapsule
RouteOral
Strengtheq 5mg base; eq 20mg base; eq 10mg base
Market StatusPrescription
CompanyAegerion

5 Pharmacology and Biochemistry
5.1 FDA Pharmacological Classification
5.1.1 Pharmacological Classes
Microsomal Triglyceride Transfer Protein Inhibitor [EPC]; Microsomal Triglyceride Transfer Protein Inhibitors [MoA]; P-Glycoprotein Inhibitors [MoA]; Cytochrome P450 3A4 Inhibitors [MoA]

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

Global Sales Information

Do you need Business Intel? Ask us

Market Place

Do you need sourcing support? Ask us

Patents & EXCLUSIVITIES

Check the patents & exclusivity for this product

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty